Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
T Stamp A | IDAI | 20. nov 2024 | 0.18 | -9.60 |
T-Mobile US | TMUS | 20. nov 2024 | 235.47 | +0.97 |
T. Rowe Price Blue Chip Growth ETF | TCHP | 20. nov 2024 | 41.64 | -0.19 |
T. Rowe Price Dividend Growth ETF | TDVG | 20. nov 2024 | 40.74 | +0.15 |
T. Rowe Price Equity Income ETF | TEQI | 20. nov 2024 | 42.57 | +0.18 |
T. Rowe Price Group | TROW | 20. nov 2024 | 117.52 | -0.36 |
T. Rowe Price Growth Stock ETF | TGRW | 20. nov 2024 | 39.39 | 0.00 |
T2 Biosystems | TTOO | 20. nov 2024 | 0.46 | -4.39 |
Taboola.com | TBLA | 20. nov 2024 | 3.30 | +4.76 |
Tactile Systems Technology | TCMD | 20. nov 2024 | 15.56 | -1.33 |
Taitron Components A | TAIT | 20. nov 2024 | 2.61 | -1.33 |
Taiwan Fund | TWN | 20. nov 2024 | 43.03 | -0.36 |
Taiwan Index MSCI Ishares | EWT | 20. nov 2024 | 53.65 | -1.03 |
Taiwan Semiconductor Manufacturing ADR | TSM | 20. nov 2024 | 188.36 | -0.69 |
Take-Two Interactive Software | TTWO | 20. nov 2024 | 185.50 | -0.27 |
Takeda Pharmaceutical ADR | TAK | 20. nov 2024 | 13.29 | -2.42 |
TAL Education Group ADR | TAL | 20. nov 2024 | 10.13 | +2.22 |
Talen Energy | TLN | 20. nov 2024 | 206.09 | -4.01 |
Talis Biomedical | TLIS | 20. nov 2024 | 4.38 | 0.00 |
Talkspace | TALK | 20. nov 2024 | 3.16 | +2.27 |
Talos Energy | TALO | 20. nov 2024 | 11.45 | +3.81 |
Talphera | TLPH | 20. nov 2024 | 0.71 | +5.42 |
Tamboran Resources | TBN | 20. nov 2024 | 17.95 | -3.80 |
Tandem Diabetes Care | TNDM | 20. nov 2024 | 30.15 | +8.18 |
Tanger | SKT | 20. nov 2024 | 36.43 | -0.22 |
Tango Therapeutics | TNGX | 20. nov 2024 | 4.08 | +5.97 |
Tantech | TANH | 20. nov 2024 | 0.16 | +1.16 |
Taoping | TAOP | 20. nov 2024 | 0.35 | -2.03 |
Tapestry | TPR | 20. nov 2024 | 55.30 | -0.58 |
Targa Resources | TRGP | 20. nov 2024 | 202.84 | -0.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.